A recent study indicates that a higher weekly dose of Wegovy, a weight-loss drug, results in greater weight loss compared to the standard dose, albeit with increased side effects. Participants receiving the higher dose lost an average of 19% of their body weight, while those on the standard dose lost 16%. The study also noted significant reductions in prediabetes cases among participants. However, higher doses led to more gastrointestinal issues and skin sensations, suggesting that while benefits may outweigh risks for some, further trials are needed.